3395100

Source:http://linkedlifedata.com/resource/pubmed/id/3395100

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004587, umls-concept:C0012655, umls-concept:C1136254, umls-concept:C1533691, umls-concept:C1707391
pubmed:issue	5
pubmed:dateCreated	1988-8-18
pubmed:abstractText	Although often dismissed as contaminants when isolated from blood cultures, Bacillus spp. are increasingly recognized as capable of causing serious systemic infections. As part of a clinical-microbiological study, 89 strains of Bacillus spp. isolated from clinical blood cultures between 1981 and 1985 had their species determined and were tested for antimicrobial agent susceptibility to 18 antibiotics. Species of isolates were determined by the API 50CH and API 20E systems. Bacillus cereus (54 strains) was the most common species isolated, followed by B. megaterium (13 strains), B. polymyxa (5 strains), B. pumilus (4 strains), B. subtilis (4 strains), B. circulans (3 strains), B. amyloliquefaciens (2 strains), B. licheniformis (1 strain), and Bacillus spp. (3 strains). Microdilution MIC susceptibility tests revealed all B. cereus strains to be susceptible to imipenem, vancomycin, chloramphenicol, gentamicin, and ciprofloxacin. Non-B. cereus strains were most susceptible to imipenem, vancomycin, LY146032, and ciprofloxacin. Disk susceptibility testing suggested that B. cereus was rarely susceptible to penicillins, semisynthetic penicillins, or cephalosporins with the exception of mezlocillin. In contrast, many non-B. cereus strains were susceptible to penicillins, semisynthetic penicillins, and cephalosporins, but marked variability was noted among species.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-105158, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-13944444, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-3103191, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-3106749, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-3313251, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-3562146, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-3571476, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-4356715, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-5424451, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-5543218, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-6408023, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-6413550, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-6432953, http://linkedlifedata.com/resource/pubmed/commentcorrection/3395100-6798519
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0315061
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0066-4804
pubmed:author	pubmed-author:RutalaW AWA, pubmed-author:SaviteerS MSM, pubmed-author:ThomannC ACA, pubmed-author:WeberD JDJ
pubmed:issnType	Print
pubmed:volume	32
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	642-5
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:3395100-Anti-Bacterial Agents, pubmed-meshheading:3395100-Bacillus, pubmed-meshheading:3395100-Humans, pubmed-meshheading:3395100-Microbial Sensitivity Tests, pubmed-meshheading:3395100-Retrospective Studies, pubmed-meshheading:3395100-Sepsis
pubmed:year	1988
pubmed:articleTitle	In vitro susceptibility of Bacillus spp. to selected antimicrobial agents.
pubmed:affiliation	Division of Infectious Diseases, University of North Carolina at Chapel Hill, 27599-7030.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't